Left Ventricular Ejection Time on Echocardiography Predicts Long-Term Mortality in Light Chain Amyloidosis

Journal of the American Society of Echocardiography

Volumn 22, Issue 12, 2009, Pages 1396-1402

  Migrino, Raymond Q ^a   Mareedu, Ravi K ^a   Eastwood, Daniel ^a   Bowers, Mark ^a   Harmann, Leanne ^a   Hari, Parameswaran ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Amyloidosis; Cardiomyopathy; Echocardiography; Heart failure; Ventricular function

Indexed keywords

ALKALINE PHOSPHATASE; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLOIDOSIS; ARTICLE; CARDIOMYOPATHY; CAUSE OF DEATH; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEMALE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION TIME; HIGH RISK PATIENT; HUMAN; IMAGING SYSTEM; KAPLAN MEIER METHOD; LABORATORY TEST; MALE; MORTALITY; PREDICTION; PROGNOSIS; SURVIVAL RATE;

AMYLOIDOSIS; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; GERMANY; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SAFETY MANAGEMENT; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; SURVIVAL ANALYSIS; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 70450253173     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2009.09.012     Document Type: Article

References (37)

1. Comenzo R.L., Vosburgh E., Simms R.W., Bergethon P., Sarnacki D., Finn K., et al. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood 88 (1996) 2801-2806
2. Falk R.H. Diagnosis and management of the cardiac amyloidoses. Circulation 112 (2005) 2047-2060
3. Sanchorawala V., Wright D.G., Seldin D.C., Dember L.M., Finn K., Falk R.H., et al. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant 28 (2001) 637-642
4. Kyle R.A., and Gertz M.A. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 32 (1995) 45-59
5. Dispenzieri A., Gertz M.A., Kyle R.A., Lacy M.Q., Burritt M.F., Therneau T.M., et al. Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood 104 (2004) 1881-1887
6. Klein A.L., Hatle L.K., Burstow D.J., Seward J.B., Kyle R.A., Bailey K.R., et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 13 (1989) 1017-1026
7. Klein A.L., Hatle L.K., Taliercio C.P., Taylor C.L., Kyle R.A., Bailey K.R., et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 16 (1990) 1135-1141
8. Siqueira-Filho A.G., Cunha C.L., Tajik A.J., Seward J.B., Schattenberg T.T., and Giuliani E.R. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation 63 (1981) 188-196
9. Koyama J., Davidoff R., and Falk R.H. Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr 17 (2004) 36-44
10. Koyama J., Ray-Sequin P.A., Davidoff R., and Falk R.H. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol 89 (2002) 1067-1071
11. Bellavia D., Pellikka P.A., Abraham T.P., Al-Zahrani G., Dispenzieri A., Oh J., et al. "Hypersynchronization" by tissue velocity imaging in patients with cardiac amyloidosis. Heart (British Cardiac Society) 95 (2008) 234-240
12. Migrino R.Q., Harmann L., Woods T., Bright M., Truran S., and Hari P. Intraventricular dyssynchrony in light chain amyloidosis: a new mechanism of systolic dysfunction assessed by 3-dimensional echocardiography. Cardiovasc Ultrasound 6 (2008) 40
13. Klein A.L., Hatle L.K., Taliercio C.P., Oh J.K., Kyle R.A., Gertz M.A., et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation 83 (1991) 808-816
14. Tei C., Dujardin K.S., Hodge D.O., Kyle R.A., Tajik A.J., and Seward J.B. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 28 (1996) 658-664
15. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
16. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
17. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and blood vessels (1964), Little Brown, Boston
18. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
19. Alam M., Wardell J., Andersson E., Nordlander R., and Samad B. Assessment of left ventricular function using mitral annular velocities in patients with congestive heart failure with or without the presence of significant mitral regurgitation. J Am Soc Echocardiogr 16 (2003) 240-245
20. Nikitin N.P., Loh P.H., Silva R., Ghosh J., Khaleva O.Y., Goode K., et al. Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction. Heart (British Cardiac Society) 92 (2006) 775-779
21. Dubrey S.W., Cha K., Anderson J., Chamarthi B., Reisinger J., Skinner M., et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 91 (1998) 141-157
22. Sirohi B., and Powles R. Epidemiology and outcomes research for MGUS, myeloma and amyloidosis. Eur J Cancer 42 (2006) 1671-1683
23. Maceira A.M., Joshi J., Prasad S.K., Moon J.C., Perugini E., Harding I., et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111 (2005) 186-193
24. Migrino R.Q., Christenson R., Szabo A., Bright M., Truran S., and Hari P. Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up. BMC Med Phys 9 (2009) 5
25. Murakami Y., Hozawa A., Okamura T., and Ueshima H. Relation of blood pressure and all-cause mortality in 180,000 Japanese participants: pooled analysis of 13 cohort studies. Hypertension 51 (2008) 1483-1491
26. Chan G.S., Middleton P.M., Celler B.G., Wang L., and Lovell N.H. Automatic detection of left ventricular ejection time from a finger photoplethysmographic pulse oximetry waveform: comparison with Doppler aortic measurement. Physiol Meas 28 (2007) 439-452
27. Lewis R.P. Diagnostic value of systolic time intervals in man. Cardiovasc Clin 6 (1975) 245-264
28. Lewis R.P., Rittogers S.E., Froester W.F., and Boudoulas H. A critical review of the systolic time intervals. Circulation 56 (1977) 146-158
29. Weissler A.M., Harris W.S., and Schoenfeld C.D. Bedside technics for the evaluation of ventricular function in man. Am J Cardiol 23 (1969) 577-583
30. Geeraerts T., Albaladejo P., Declere A.D., Duranteau J., Sales J.P., and Benhamou D. Decrease in left ventricular ejection time on digital arterial waveform during simulated hypovolemia in normal humans. J Trauma 56 (2004) 845-849
31. Wizenberg T.A., Muz J., Sohn Y.H., Samlowski W., and Weissler A.M. Value of positive myocardial technetium-99 m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis. Am Heart J 103 4 Pt 1 (1982) 468-473
32. Cheng H.M., Yu W.C., Sung S.H., Wang K.L., Chuang S.Y., and Chen C.H. Usefulness of systolic time intervals in the identification of abnormal ventriculo-arterial coupling in stable heart failure patients. Eur J Heart Fail 10 (2008) 1192-1200 Epub 2008 Nov 11
33. Gertz M.A., Lacy M.Q., Dispenzieri A., Hayman S.R., and Kumar S. Transplantation for amyloidosis. Curr Opin Oncol 19 (2007) 136-141
34. Jantunen E., Itala M., Lehtinen T., Kuittinen O., Koivunen E., Leppa S., et al. Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients. Eur J Haematol 76 (2006) 245-250
35. Vesole D.H., Perez W.S., Akasheh M., Boudreau C., Reece D.E., and Bredeson C.N. High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: a Center for International Blood and Marrow Transplant Research Study. Mayo Clinic Proc 81 (2006) 880-888
36. Comenzo R.L., and Gertz M.A. Autologous stem cell transplantation for primary systemic amyloidosis. Blood 99 (2002) 4276-4282
37. Bellavia D., Abraham T.P., Pellikka P.A., Al-Zahrani G.B., Dispenzieri A., Oh J.K., et al. Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. J Am Soc Echocardiogr 20 (2007) 1194-1202